Cell and tissue-based in vitro models for improving the development of oral inhalation drug products.

The interplay of costs and ethics has increased the need for adequate models mimicking the human in vivo situation drastically. An adequate model has the ability to generate data which are predictive for a certain aspect of the human response, for example for the bioavailability. This review highlights how in vitro models can enrich pulmonary drug delivery research with more detailed insights in cellular and non-cellular barriers, allowing for faster improvements and significant innovations of inhalation drug products. Risk assessment in inhalation toxicology and aerosol medicines and related important guidelines (e.g. OECD, EMA) are mentioned as a fundament for the described methods. Principle decisions to find a suitable in vitro tool for the question being asked are discussed to support the individual selection. Depending on the cellular and non-cellular barrier, exemplary in vitro tools are described with their ability to reflect a certain part of the in vivo lung situation. The review closes with a short summary of more complex systems as well as their advantages and limitations.

[1]  M. Matthay,et al.  Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[2]  U. Fischer,et al.  Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier. , 2016, ALTEX.

[3]  Claus-Michael Lehr,et al.  The Interplay of Lung Surfactant Proteins and Lipids Assimilates the Macrophage Clearance of Nanoparticles , 2012, PloS one.

[4]  C. Lehr,et al.  The Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) In Vitro System: Design and Experimental Protocol , 2010, Alternatives to laboratory animals : ATLA.

[5]  Claus-Michael Lehr,et al.  Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models. , 2015, Advanced drug delivery reviews.

[6]  J. Knebel,et al.  Novel approaches for studying pulmonary toxicity in vitro. , 2003, Toxicology letters.

[7]  Thomas Geiser,et al.  A lung-on-a-chip array with an integrated bio-inspired respiration mechanism. , 2015, Lab on a chip.

[8]  H. Magnussen,et al.  The early allergic response in small airways of human precision-cut lung slices , 2003, European Respiratory Journal.

[9]  Donald E Ingber,et al.  Engineered in vitro disease models. , 2015, Annual review of pathology.

[10]  N. Willenbacher,et al.  Size-Limited Penetration of Nanoparticles into Porcine Respiratory Mucus after Aerosol Deposition. , 2016, Biomacromolecules.

[11]  F. Dionnet,et al.  Toxicity of diesel engine exhausts in an in vitro model of lung slices in biphasic organotypic culture: induction of a proinflammatory and apoptotic response , 2000, Archives of Toxicology.

[12]  F. Barile,et al.  Acute cytotoxicity testing with cultured human lung and dermal cells , 1998, In Vitro Cellular & Developmental Biology - Animal.

[13]  Peter Wick,et al.  Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro , 2012, Particle and Fibre Toxicology.

[14]  J. Castell,et al.  Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach. , 2005, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[15]  V. Kosma,et al.  Toxicity of richterite in hemolysis test and macrophage cultures. , 1986, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[16]  G. Woodworth,et al.  Nanoparticle diffusion in respiratory mucus from humans without lung disease. , 2013, Biomaterials.

[17]  Peter Wick,et al.  A comparative study of different in vitro lung cell culture systems to assess the most beneficial tool for screening the potential adverse effects of carbon nanotubes. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[19]  Claus-Michael Lehr,et al.  Influence of agglomeration and specific lung lining lipid/protein interaction on short-term inhalation toxicity , 2016, Nanotoxicology.

[20]  Ivan Rusyn,et al.  In vitro models for liver toxicity testing. , 2013, Toxicology research.

[21]  M Liebsch,et al.  Prevalidation of the ex-vivo model PCLS for prediction of respiratory toxicity. , 2016, Toxicology in vitro : an international journal published in association with BIBRA.

[22]  D. Kirschner,et al.  Computational Modeling Predicts Simultaneous Targeting of Fibroblasts and Epithelial Cells Is Necessary for Treatment of Pulmonary Fibrosis , 2016, Front. Pharmacol..

[23]  M. Guerbet,et al.  Acrolein toxicity: comparative in vitro study with lung slices and pneumocytes type II cell line from rats. , 1999, Toxicology.

[24]  M. A. Mason,et al.  A Quantitative Technique for Studying the Effect of Dust on Phagocytic Cells in vitro , 1956, British journal of industrial medicine.

[25]  C. Acquadro,et al.  PND39 What is the Influence on Clinical Research of the EMA Guideline on Medicinal Products for the Treatment of Alzheimer's Disease? , 2012 .

[26]  R. McClellan,et al.  Cytotoxicity and mutagenicity of vapor-phase pollutants in rat lung epithelial cells and Chinese hamster ovary cells grown on collagen gels. , 1983, Journal of toxicology and environmental health.

[27]  A. Braun,et al.  Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS). , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[28]  M. Fall,et al.  Biphasic culture of rat lung slices for pharmacotoxicological evaluation of complex atmospheres , 2004, Cell Biology and Toxicology.

[29]  B. Forbes,et al.  In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  Claus-Michael Lehr,et al.  The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier. , 2014, Molecular pharmaceutics.

[31]  Robert Landsiedel,et al.  In vivo-in vitro comparison of acute respiratory tract toxicity using human 3D airway epithelial models and human A549 and murine 3T3 monolayer cell systems. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[32]  Robert Landsiedel,et al.  Applicability of rat precision-cut lung slices in evaluating nanomaterial cytotoxicity, apoptosis, oxidative stress, and inflammation. , 2014, Toxicology and applied pharmacology.

[33]  S. Poulsen,et al.  Mechanism of Action of Lung Damage Caused by a Nanofilm Spray Product , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  S. Larsen,et al.  An in vitro method for predicting inhalation toxicity of impregnation spray products. , 2015, ALTEX.

[35]  B. Rothen‐Rutishauser,et al.  Mimicking exposures to acute and lifetime concentrations of inhaled silver nanoparticles by two different in vitro approaches , 2014, Beilstein journal of nanotechnology.

[36]  Pakatip Ruenraroengsak,et al.  Critical Determinants of Uptake and Translocation of Nanoparticles by the Human Pulmonary Alveolar Epithelium , 2014, ACS nano.